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Background/Aims: symptomatic central venous obstruction (CVO) in dialysis patients with arteriovenous fistulas
(AVFs) leads to significant morbidity and patient inconvenience. We evaluated the results of surgical and radiological
interventional treatment of symptomatic central venous obstruction.
Methods: clinical data, site and length of vein obstruction, type and outcome of intervention were obtained from patient
records. Patency rates of radiological and surgical treatment were calculated using Life Table survival analysis.
Results: in 28 patients with VH, 45 interventions (percutaneous intervention 30; surgical reconstruction 10; AVF closure
five) were performed. Mean vessel obstruction length was 4.9 cm, mainly localized in the subclavian vein (55%). Initial
clinical success rate of PTA and surgery was 92%, with complications after percutaneous transluminal angioplasty (PTA)
on six occasions. Restenosis after PTA was observed in 39%. One-year primary and secondary patency after PTA was 50
and 63%, respectively. One-year primary patency after surgical reconstruction was 75%.
Conclusion: symptomatic CVO in dialysis patients with AVFs can be treated with a high success rate through radiological
intervention. Surgical reconstruction is an appropriate alternative method in case of failed PTA.
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Central venous obstruction is usually accompanied by
few if any complications. However symptoms, mani-
fested by severe arm swelling, pain, and venous ulcers
as a result of central venous obstruction in patients
with ipsilateral arteriovenous fistulas for hemo-
dialysis, endangers the usefulness of the vascular
access1,2 and result in significant morbidity of the
patient. Venous outflow obstructions are considered
to be due to high flow states and occur at sites of
turbulence.3,4 Moreover, placement of long-term jugu-
lar or subclavian vein catheters has been recognized as
a significant risk factor.5,6
The most favorable treatment of symptomatic
venous obstruction is still topic of discussion. Differ-
ent treatment entities have been used to correct central
venous lesions, including percutaneous radiological
(endovascular) procedures and surgical reconstruc-
tion. Studies describing surgical reconstruction, like
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reported patency rates of approximately 80% at
1 year.7±10 Radiological interventions, including
recanalisation, percutaneous transluminal angioplasty
(PTA) with or without additional stent placement
show similar patency rates of 70±90% at 1-year
follow-up.10±14
The current study was performed to determine the
clinical success and patency rates of surgical and
radiological interventions to eliminate symptomatic
central venous obstruction in patients depending on
hemodialysis vascular access in a single center.
Patients and Methods
From 1991 through 2002, 28 patients (16 male; mean
age SE 66.1 3.0 year) were treated for sympto-
matic central venous obstruction, with symptoms of
arm swelling, pain, and ulcerations. Clinical data and
outcome of surgical and radiological interventions
were retrospectively collected from patient records.
Different types of vascular access for hemodialysis
were used: 11 patients had forearm prosthetic looprights reserved.
318 R. Dammers et al.(PTFE) AVFs, nine patients with autogenous wrist
AVFs (radiocephalic), six patients with upper arm
brachio-cephalic (2) and basilic vein transposition (4),
and two patients with subclavian artery-to-vein
(thorax loop) PTFE grafts. Twenty-four patients
(86%) had a history of previous central vein catheters,
of which 15 patients had subclavian vein catheters
and nine had jugular vein catheters. Central vein
pathology was visualized by digital subtraction
angiography (DSA) by means of antegrade contrast
injection into the vascular access. From 1991 to 1995,
the primary treatment option was surgical interven-
tion, while after 1995, radiological intervention was
attempted as the preferred primary therapy. The inter-
ventional method of choice was considered to be PTA.
However, in case of elastic recoil and a long-segment
venous obstruction, a primary stent or recanalisation
with stent placement was performed.
All patients were subdue to clinical examination
and Duplex ultrasonography at regular three-month
intervals. In case of symptomatic restenosis, patients
were treated by means of re-PTA or reconstructive
surgery.
Radiological techniques
Before angioplasty or stent deployment, subtraction
angiography (DSA) was performed to study the ana-
tomic and pathologic characteristics of the vessel after
antegrade venous puncture of a fistula vein or the
graft itself with a 4-French straight catheter (Cordis,
Johnson & Johnson, Roden, The Netherlands).
Recanalization usually was attempted with an upper
arm venous approach using a hydrophilic-coated,
steerable, 0.035-inch guide wire (Terumo, Leuven,
Belgium). After safe passage of the obstructed seg-
ment and subsequent exchange of guide wire to
a stiff 0.035 inch guide wire (Boston Scientific,
Watertown, MA, U.S.A.), a balloon catheter of adequate
diameter, usually 8±10 mm (Cordis, Johnson & Johnson,
Roden, The Netherlands), was advanced into the seg-
ment and dilated. `` Through-and-through'' access,
where the transbrachially placed guide wire is pulled
out through the femoral vein access, was performed
when stent placement was deemed necessary. A flex-
ible, self-expanding Wall-stent (Boston Scientific,
Watertown, MA, U.S.A.) was introduced through a
9-French sheath placed in the common femoral vein.
Correction of the Wall-stent position for exact place-
ment was performed by pulling the partially deployed
stent to the affected region. Stents were dilated with
a balloon of suitable size after deployment to ensure as
close a contact to the venous wall as possible.Eur J Vasc Endovasc Surg Vol 26, September 2003Surgical techniques
Jugular vein transposition
This technique has been described previously.9 The
axillary or cephalic vein is dissected by a horizontal
incision just caudal to the clavicle. After splitting of
the major pectoral muscle and opening the fascia, the
cephalic or axillary vein is dissected free of the adja-
cent fatty tissue. The external or internal jugular vein
is exposed through a vertical neck incision. After
clamping, the jugular vein is transsected as high as
possible and transposed through a subcutaneous
tunnel in front of the clavicle towards the infraclavi-
cular axillary or cephalic vein. Subsequently, an
end-to-side anastomosis with running prolene 7 0
is performed. Patency of the bypass is peroperatively
determined by completion angiography. Subcuta-
neous tissue and skin are closed with interrupted
sutures.
Jugular vein bypass
The internal jugular vein is exposed through a hori-
zontal neck incision 2 cm cranial to the clavicle. Then,
the cephalic or axillary vein is explored in the upper
arm. A subcutaneous tunnel, anterior to the clavicle is
then accomplished through which a 6 mm ringed
stretch PTFE (Gore-Tex1, W.L. Gore & Associates,
Flagstaff, Arizona, U.S.A.) vascular graft is placed.
Subsequently, the graft is anastomosed in an end-to-
side manner to the jugular vein and the upper arm
vein with a running prolene 7 0. Patency of the graft
is peroperatively determined by completion angio-
graphy. Subcutaneous tissue and skin are closed with
interrupted sutures.
Axillary±axillary cross-over bypass
The axillary vein is dissected by an horizontal infra-
clavicular incision. After splitting of the pectoral
muscle the vein is localized and handled by vessel
loops. A 6 mm ringed PTFE prosthesis (Gore-Tex1,
W.L. Gore & Associates, Flagstaff, Arizona, U.S.A.) is
then inserted into a subcutaneous tunnel in front of
the sternum. Graft-to-vein anastomoses are performed
with running 7 0 polyprophylene sutures. After
completion angiography the subcutaneous tissue and
skin are closed with interrupted sutures.
Statistical analysis
Statistical analysis was performed using the SPSS 10.0
package (SPSS, Chicago, Ill, U.S.A.). Initial clinical
success, primary and secondary patency of surgical
and radiological intervention were estimated by Life
Table 1. Life table analysis of primary patency rate of percuta-
neous transluminal angioplasty of central venous obstruction.
Interval
(mts)
At risk Failure Died LFU Cum
patency (%)
SE
(%)
0±3 20 5 2 1 95 4.8
3±6 12 2 ± ± 63 11.4
6±9 10 2 ± ± 50 11.9
9±12 8 ± 1 ± 50 12.1
LFU lost to follow up; SE standard error.
Table 2. Life table analysis of secondary patency rate of percuta-
neous transluminal angioplasty of central venous obstruction.
Interval
(mts)
At risk Failure Died LFU Cum
patency (%)
SE
(%)
0±3 20 1 2 1 95 4.9
3±6 16 1 ± ± 88 6.1
6±9 15 1 ± ± 78 9.7
9±12 14 2 1 ± 63 11.2
LFU lost to follow up; SE standard error.
Table 3. Life table analysis of primary patency rate of surgical
reconstruction for central venous obstruction.
Interval
(mts)
At risk Failure Died LFU Cum
patency (%)
SE
(%)
0±3 8 1 ± ± 88 9.8
3±6 7 1 ± ± 75 11.7
6±9 6 ± ± ± 75 15.3
9±12 6 ± ± ± 75 17.2
LFU lost to follow up; SE standard error.
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trend analysis.
Results
A total of 45 interventions (radiological: 30; surgical 15)
were performed in 28 patients with vascular accesses
and symptomatic CVO. The mean (SE) duration of
AVF insertion was 368 317 days (range: 79±921
days).
Angiographically demonstrated venous obstruction
was localized in the subclavian vein in 15 patients
(46% right side); six patients had an axillary vein
obstruction (50% right), and seven patients had an
obstruction localized in the brachiocephalic trunc
(60% right side). Central venous occlusion was seen
in 17 patients and the other 11 patients presented with
a significant stenosis (450% diameter reduction).
Mean (SE) overall length of these obstructions was
4.9 0.5 cm (range: 1±8.5 cm).
PTA was the therapy of first choice in 20 patients.
Initial clinical success of angioplasty alone with com-
plete relief of symptoms and AVF salvage was
achieved in 18 out of 20 patients. In two patients the
obstruction persisted and subsequently in the same
session a Wall-stent was placed. Minor complications
occurred in six patients resulting in dissection (1),
Wall-stent dislocation (1), and limited contrast extra-
vasate (4). The dissection was successfully treated
by stent implantation. Stent dislocation was solved
by the insertion of an overlapping anchoring stent. In
three of four patients with an extravasate during PTA,
angioplasty was still successful. Recanalisation of an
occluded subclavian vein could not be achieved in one
patient, and a conservative treatment was chosen. In
this patient the AVF remained functional for hemo-
dialysis therapy. Late restenosis with recurrence of
limb edema occurred in nine patients within a mean
time period of 4.8 months (range: 1.1±15.1 months).
These patients were treated by re-PTA or stent place-
ment in seven cases and through surgery in two
patients. In these patients a jugular vein transposition
(1) and a bypass graft from the cephalic vein to the
ipsilateral internal jugular vein (1) were performed.
Patients with failed PTA had mainly central vein
obstructions and not stenoses.
A primary surgical procedure was choosen in eight
patients and as a second choice therapy (after failed
radiological intervention) in another two patients. In
total, five jugular vein transpositions, three jugular
vein bypass grafts, and two bypasses to the contra-
lateral jugular or axillary vein were performed. No
major morbidity or mortality in the operated patientswere observed. Due to failure of the surgical or radio-
logical procedure in five patients, surgical closure of
the AVF was needed. Surgery was thus effective in
alleviating arm swelling in eight out of 10 patients,
whereas the efficacy of AVF closure in five patients
was 100%.
Overall initial success rate of radiological and sur-
gical intervention was 92%. Primary patency after
PTA was 63% at 6 months and 50% at 12 months of
follow-up (Table 1). Secondary patencies were 88%
and 63% at 6 and 12 months, respectively (Table 2).
Primary patency after surgical reconstruction was 75%
at 12 months (Table 3). No significant difference in
patency rates between radiological and surgical inter-
vention could be demonstrated.
Discussion
During the past two decades, large-bore catheters
suitable for insertion into the subclavian or internal
jugular vein, have been increasingly used not only forEur J Vasc Endovasc Surg Vol 26, September 2003
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longer periods of hemodialysis treatment. After initial
enthusiasm, scepsis and pessimism evoked because of
the high incidence of infectious and thrombotic com-
plications of central vein catheters. Moreover the risk
on central venous obstruction after catheter placement
endangers the possibility of future ipsilateral vascular
access placement. According to several studies the
incidence of subclavian vein obstruction due to cathe-
ters ranges from 12 to 29%.1,6,14 and internal jugular
vein obstruction may occur in about 5% of patients.
In the present study, new AVFs were created in
425 patients between 1991 and 2002 of which 28 patients
developed symptomatic central venous obstruction
for which treatment was necessary. This is an inci-
dence of 7%. In the majority of patients, central venous
obstruction is caused by long-term indwelling central
vein catheters (82±100%)1,3,5±7,10,11,13 and occasionally
a permanent pacemaker wire is the culprit.15 In the
present study, 83% of the patients had a history of
previous central vein catheters either in the subclavian
or internal jugular vein position.
In recent years, a percutaneous approach for the
treatment of central venous obstruction became popu-
lar as the treatment of first choice. For this reason, we
started also after an initially surgical approach, to use
radiological intervention, because of its minimally
invasiveness. Initially, the intervention consisted
either of balloon angioplasty alone or additional
stent placement in case of elastic recoil or failure of
PTA. Various studies have addressed to the use of
angioplasty with or without stenting in case of central
venous obstructions in patients with vascular accesses,
reporting initial clinical success in approximately 96%
of cases and 1-year primary patencies of 17±
70%.1,3,6,8,11±14 Restenosis rates vary from 14 to 33%
and with a policy of multiple re-PTAs, an one-year
secondary patency of 47 to 100% can be achieved.
The results of these retrospective studies corroborate
well with the findings of the present study
(1-year primary and secondary patency: 50 and 63%,
respectively).
Some authors advocate initial stent placement with
PTA only in the case of recurrent stenosis and from
this study a 56% primary and 97% secondary patency
rate was reported.14 One may debate whether primary
stent placement should be the treatment of choice. We
achieved a favourable initial success rate of 89% with
angioplasty alone in most patients However symp-
tomatic restenosis was seen in 39% within 4.8 months,
and these restenoses could successfully be treated
with re-PTA, stent placement or surgery. With this
treatment policy a secondary patency of 63% after
1 year of follow up was achieved and this patency isEur J Vasc Endovasc Surg Vol 26, September 2003comparable to the results of several studies, but worse
in comparison with primary stent placement.
Primary surgical treatment in our hands had an
acceptable outcome with relief of symptoms in 75%
of patients. However, surgery failed in two patients
because of a severely diseased internal jugular vein
with the inability to perform an adequate anastomosis
or insufficient venous drainage through a cephalic-
jugular vein bypass in combination with a high flow
AVF. Bhatia et al.10 have reported an 1 year patency of
71% after PTA and stent placement and 83% after
surgical reconstruction (internal jugular vein trans-
position and subclavian-to-innominate vein bypasses).
Other studies have also shown good patency rates
after surgical reconstruction at 1 year follow up
(approximately 80%).8,9,16,17 Furthermore, Duncan et al.
suggested subclavian vein-to-right atrial bypass
grafting as an alternative treatment option when all
other treatment modalities are exhausted.7,18 We
strongly believe that when radiological intervention
is not feasible, surgery should be considered with an
attempt to salvage of the AVF. The historical treatment
of symptomatic CVO in patients with hemodialysis
access was to ligate the AVF and to create a new access
site in the contralateral extremity. Recognition and
management was minimal and reports were uncom-
mon.2,5,20 The increase in the incidence of central ven-
ous obstruction is most probable the result of the
frequent use of temporary percutaneous catheters in
dialysis patients and physician awareness of the prob-
lem. In this respect, the American Dialysis Outcome
and Quality Initiatives (DOQI) guidelines, first
released in 1997 and updated in 2000, state that sub-
clavian vein catheterization should be avoided for
temporary access in all patients with chronic renal
failure due to the risk of central venous stenosis.19
The success of the above mentioned treatment
modalities has varied but has allowed the physician
to prolong dialysis access function for considerable
periods of time. Especially with the rapid develop-
ment of new radiological techniques, the use of endo-
vascular approaches in the treatment of central
venous obstruction has improved significantly.
Moreover, angioplasty has proven to be an adequate
minimal invasive means of improving venous hyper-
tension, although some authors believe that initial
stent placement surpasses angioplasty alone.6,12±14
From this study it was shown that radiological
intervention, either PTA alone or PTA with additional
stent placement, has similar results as surgical recon-
struction. The number of patients in this study were
small and therefore conclusions should be taken with
precaution. PTA may be choosen as the treatment of
first choice, considering its relatively noninvasive
Accepted 26 March 2003
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reconstruction remains an appropriate and reliable
alternative in case of failure of percutaneous treat-
ment. Furthermore, caution has to be regarded
towards the use of indwelling central vein catheters
for hemodialysis, for they are the number one culprit
in the origin of central venous obstructions.
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